Stopping PCP prophylaxis

被引：0
|
作者：
不详
机构：
来源：
AIDS PATIENT CARE AND STDS | 1999年 / 13卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [41] Impact of infections disease (ID) consultation on PCP prophylaxis for hospitalized HIV infected patients
    Herrera, P
    Herdegen, JJ
    Itokazu, G
    Jasek, J
    Weinstein, RA
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 251 - 251
  • [42] DAPSONE/PYRIMETHAMINE VERSUS AEROSOLIZED PENTAMIDINE AS PROPHYLAXIS AGAINST PCP IN HIV-INFECTION
    DORRELL, L
    MCCALLUM, AK
    SNOW, MH
    ONG, ELC
    AIDS PATIENT CARE, 1995, 9 (05): : 224 - 228
  • [43] ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS INDUCED BY PNEUMOCYSTIS CARINII PNEUMONIA (PCP) PROPHYLAXIS WITH DAPSONE
    Vas, A.
    Laws, P. M.
    Marsland, A. M.
    McQuillan, O.
    SEXUALLY TRANSMITTED INFECTIONS, 2012, 88 : A65 - A66
  • [44] Survival benefit associated with antiretroviral and prophylaxis against PCP and tuberculosis in patients with AIDS.
    Del Amo, J
    Blanco, F
    Gálvez, C
    Soriano, V
    Diez, M
    Rodriguez-Rosado, R
    Jiménez-Nacher, I
    González-Lahoz, J
    AIDS, 1998, 12 : S87 - S87
  • [45] PNEUMOCYSTIS-CARINII PNEUMONIA (PCP) AND PROPHYLAXIS (PX) IN HIV-INFECTED CHILDREN
    FERDMAN, RM
    CHURCH, JA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 268 - 268
  • [46] CD4+ CELLS AND CD4+ PERCENT AS RISK MARKERS FOR PNEUMOCYSTIS-CARINII PNEUMONIA (PCP) - IMPLICATIONS FOR PRIMARY PCP PROPHYLAXIS
    LIDMAN, C
    BERGLUND, O
    TYNELL, E
    LINDBACK, S
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (02) : 157 - 160
  • [47] Stopping antibacterial prophylaxis in pediatric allogeneic hematopoietic cell transplantation: An internal audit
    Wintjes, Nina
    Kraemer, Katja
    Kolve, Hedwig
    Mohring, Daniela
    Schaumburg, Frieder
    Rossig, Claudia
    Burkhardt, Birgit
    Groll, Andreas H.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [48] Dapsone for Pneumocystis carinii pneumonia (PCP) prophylaxis in children undergoing bone marrow transplantation (BMT).
    Maltezou, HC
    Petropoulos, D
    Choroszy, M
    Mullen, C
    Culbert, S
    Chan, KW
    BLOOD, 1996, 88 (10) : 3778 - 3778
  • [49] Should prophylaxis for Pneumocystis carinii pneumonia (PCP) in solid organ transplant recipients ever be discontinued?
    Larosa, S
    Gordon, S
    Kalmadi, S
    Truesdell, L
    Avery, R
    Arroliga, A
    Longworth, D
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 230 - 230
  • [50] Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific interstitial pneumonitis (NSIP)
    Gudur, Sharada
    Newton, Pippa
    Leonard, Colm
    Chaudhuri, Nazia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345